Theriva Biologics, Inc. (TOVX)
NYSE · Healthcare
Theriva Biologics, Inc. Revenue 2010–2011
Theriva Biologics, Inc. annual/quarterly revenue history and growth rate from 2010 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Theriva Biologics, Inc. revenue for the quarter ending March 31, 2026 was 300000.
- Theriva Biologics, Inc. revenue for the twelve months ending March 31, 2026 was 1.2 M.
- Theriva Biologics, Inc. annual revenue for 2011 was 0, a 100.00% decrease from 2010.
- Theriva Biologics, Inc. annual revenue for 2010 was 2.6 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Theriva Biologics, Inc. Earnings — FAQ
Theriva Biologics, Inc. (TOVX) earnings over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TOVX's earnings history?
The chart and table above show Theriva Biologics, Inc.'s earnings by year and by quarter, including the growth rate.